IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.

Kerri  Joseph

SVice President of Investment Relation & Treasury

Mr. W. Richard Staub III

President of Research & Development Solutions

Dr. Jeffrey A. Spaeder M.D.

Senior Vice President, Global Chief Medical & Scientific Officer

Mr. Kevin C. Knightly

President of Corporate Strategy & Enterprise Networks

Mr. Eric M. Sherbet

Executive Vice President, General Counsel & Secretary

Ms. Keriann  Cherofsky

Senior Vice President, Corporate Controller & Chief Accounting Officer

Mr. Jim  Berkshire

Executive Vice President of Global Technology & Operations

Ms. Trudy  Stein

Chief Human Resources Officer & Executive Vice President

Mr. Ari  Bousbib

Chief Executive Officer & Chairman

Mr. Ronald E. Bruehlman

Executive Vice President & Chief Financial Officer

Pavadinimas	Rinkos kapitalizacija
Revvity, Inc.	0M
Genetic Technologies Limited	0M
Standard BioTools Inc.	0M
IDEXX Laboratories, Inc.	0M
China Biotech Services Holdings Limited	0M
Sonic Healthcare Limited	0M
Quest Diagnostics Incorporated	0M
Qiagen N.V.	0M
Amoy Diagnostics Co., Ltd.	0M
WuXi AppTec Co., Ltd.	0M
Shin Nippon Biomedical Laboratories, Ltd.	0M

IQVIA Holdings Inc.

IQVIA Holdings Inc. Konkurentų sąrašas

Pagrindiniai konkurentai